Literature DB >> 17614812

Fixed drug eruption to cetirizine with positive lesional patch tests to the three piperazine derivatives.

Mariana Cravo1, Margarida Gonçalo, Américo Figueiredo.   

Abstract

BACKGROUND: The H1-antihistamine cetirizine, a piperazine derivative widely used in daily practice, is rarely the cause of cutaneous drug reaction. Nevertheless, four cases of fixed drug eruption (FDE) as a result of this drug have been described recently. We present the case of a 45-year-old woman with a multilocalized FDE following oral intake of cetirizine for allergic rhinitis.
METHODS: Patch testing with hydroxyzine 1% and 10% in petrolatum (Chemotechnique), and with powdered Zyrtec (cetirizine) and Xyzal (levocetirizine) pills, prepared at 20% in water and at 20% in petrolatum, was performed in both residual lesions and healthy skin.
RESULTS: Positive results (++) to these drugs (24 h occlusion and readings at days 2 and 3) were obtained in residual lesions only. These results allowed us to confirm the drug responsible for this FDE and to study cross-reactions between antihistamines of the same chemical family.
CONCLUSIONS: To the best of our knowledge, this is the first report of FDE to cetirizine with positive patch testing to hydroxyzine, cetirizine, and levocetirizine. This case highlights the importance of patch testing in the study of cutaneous drug reactions, namely FDE.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17614812     DOI: 10.1111/j.1365-4632.2007.03131.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  9 in total

Review 1.  Paradoxical and bidirectional drug effects.

Authors:  Silas W Smith; Manfred Hauben; Jeffrey K Aronson
Journal:  Drug Saf       Date:  2012-03-01       Impact factor: 5.606

2.  Fixed Drug Eruption to Cetirizine: An Unusual Villain.

Authors:  Kenit P Ardeshna; Shaurya Rohatgi; Hemangi R Jerajani
Journal:  Indian Dermatol Online J       Date:  2018 Jan-Feb

3.  A case of chlorpheniramine maleate-induced hypersensitivity with aspirin intolerance.

Authors:  Min-Hye Kim; Sang-Min Lee; So-Hee Lee; Hyouk-Soo Kwon; Sae-Hoon Kim; Sang-Heon Cho; Kyung-Up Min; You-Young Kim; Yoon-Seok Chang
Journal:  Allergy Asthma Immunol Res       Date:  2010-07-29       Impact factor: 5.764

4.  A case of levocetirizine-induced fixed drug eruption and cross-reaction with piperazine derivatives.

Authors:  Mi-Yeong Kim; Eun-Jung Jo; Yoon-Seok Chang; Sang-Heon Cho; Kyung-Up Min; Sae-Hoon Kim
Journal:  Asia Pac Allergy       Date:  2013-10-31

5.  Fixed drug eruption to levocetirizine and cetirizine.

Authors:  Lalit Kumar Gupta; Nidheesh Agarwal; Ashok Kumar Khare; Asit Mittal
Journal:  Indian J Dermatol       Date:  2014-07       Impact factor: 1.494

6.  Fixed drug eruption due to levocetirizine.

Authors:  Ratinder Jhaj; Dinesh Prasad Asati; Deepa Chaudhary
Journal:  J Pharmacol Pharmacother       Date:  2016 Apr-Jun

7.  Fixed Drug Eruption Induced by Levocetirizine.

Authors:  Isa An; Vasfiye Demir; Ibrahim Ibiloglu; Sedat Akdeniz
Journal:  Indian Dermatol Online J       Date:  2017 Jul-Aug

8.  Unusual and Interesting Adverse Cutaneous Drug Reactions.

Authors:  Vaishali Masatkar; Ashok Nagure; Lalit Kumar Gupta
Journal:  Indian J Dermatol       Date:  2018 Mar-Apr       Impact factor: 1.494

9.  Fixed-drug Eruptions: What can we Learn from a Case Series?

Authors:  Ratinder Jhaj; Deepa Chaudhary; Dinesh Asati; Balakrishnan Sadasivam
Journal:  Indian J Dermatol       Date:  2018 Jul-Aug       Impact factor: 1.494

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.